Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
Powered by cricketnext logo
News18 » India
1-min read

Dr Reddy's Recalls 2.36 Lakh Bottles of Cholesterol Lowering Tablets From US

The firm is also recalling 6,397 bottles of 80 mg on account of "presence of foreign substance: A product complaint was received for a defective tablet with an embedded foreign object observed in a bottle," regulator USFDA said.

PTI

Updated:July 1, 2018, 6:18 PM IST
facebookTwitter Pocket whatsapp
Dr Reddy's Recalls 2.36 Lakh Bottles of Cholesterol Lowering Tablets From US
Image for representation. (AFP)

New Delhi: Dr Reddy's Laboratories is recalling from the US over 2.36 lakh bottles of Atorvastatin Calcium tablets used for lowering cholesterol, as per a report by the US health regulator.

Dr Reddy's Labs Inc is recalling 2.30 lakh bottles of the tablets on account of "failed impurities/ degradation specifications," regulator USFDA said in its Enforcement Report. These recalled tablets are in the strengths of 10 mg, 20 mg and 40 mg.

Out of the total bottles being recalled, 55,126 are of 10 mg strength, 44,894 bottles of 20 mg and 1,30,081 bottles are of 40 mg, it added.

The firm is also recalling 6,397 bottles of 80 mg on account of "presence of foreign substance: A product complaint was received for a defective tablet with an embedded foreign object observed in a bottle," the report said.

The tablets were manufactured by Dr Reddy's Labs at its Srikakulam facility, it said.

The voluntary recall for the 10 mg, 20 mg and 40 mg tablets from the US and Puerto Rico is a class III recall, it added.

For the 80 mg tablets, the recall is of class II, USFDA said.

As per USFDA, a class II recall is initiated in a "situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."

A class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

| Edited by: Aditya Nair
Read full article
Next Story
Next Story

facebookTwitter Pocket whatsapp

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results